Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study ; volume:20 ; number:1 ; day:25 ; month:3 ; year:2020 ; pages:1-10 ; date:12.2020
BMC pediatrics ; 20, Heft 1 (25.3.2020), 1-10, 12.2020
- Urheber
-
van Katwyk, Sasha
Augustine, Sajit
Thébaud, Bernard
Thavorn, Kednapa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12887-020-02037-5
- URN
-
urn:nbn:de:101:1-2020061619150919934346
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- van Katwyk, Sasha
- Augustine, Sajit
- Thébaud, Bernard
- Thavorn, Kednapa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Virus infections as risk factors in the development of bronchopulmonary dysplasia (BPD)
Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis
Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
The association between βeta 2-microglobulin and bronchopulmonary dysplasia
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
Virus infections as risk factors in the development of bronchopulmonary dysplasia (BPD)
Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis
Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
The association between βeta 2-microglobulin and bronchopulmonary dysplasia
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
Virus infections as risk factors in the development of bronchopulmonary dysplasia (BPD)
Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis
Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
The association between βeta 2-microglobulin and bronchopulmonary dysplasia